McCarthy MK - Search Results

1

The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates.

Prow NA, Liu L, McCarthy MK, Walters K, Kalkeri R, Geiger J, Koide F, Cooper TH, Eldi P, Nakayama E, Diener KR, Howley PM, Hayball JD, Morrison TE, Suhrbier A. Prow NA, et al. Among authors: mccarthy mk. NPJ Vaccines. 2020 Jun 2;5(1):44. doi: 10.1038/s41541-020-0191-8. eCollection 2020. NPJ Vaccines. 2020. PMID: 32550013 Free PMC article.

2

Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells.

Burrack KS, Tan JJ, McCarthy MK, Her Z, Berger JN, Ng LF, Morrison TE. Burrack KS, et al. Among authors: mccarthy mk. PLoS Pathog. 2015 Oct 5;11(10):e1005191. doi: 10.1371/journal.ppat.1005191. eCollection 2015 Oct. PLoS Pathog. 2015. PMID: 26436766 Free PMC article.

3

Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms?

McCarthy MK, Morrison TE. McCarthy MK, et al. Future Microbiol. 2016;11(3):331-4. doi: 10.2217/fmb.15.147. Epub 2016 Mar 4. Future Microbiol. 2016. PMID: 26939523 Free PMC article. No abstract available.

4

Persistent RNA virus infections: do PAMPS drive chronic disease?

McCarthy MK, Morrison TE. McCarthy MK, et al. Curr Opin Virol. 2017 Apr;23:8-15. doi: 10.1016/j.coviro.2017.01.003. Epub 2017 Feb 17. Curr Opin Virol. 2017. PMID: 28214732 Free PMC article. Review.

5

Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment.

McCarthy MK, Davenport BJ, Reynoso GV, Lucas ED, May NA, Elmore SA, Tamburini BA, Hickman HD, Morrison TE. McCarthy MK, et al. JCI Insight. 2018 Jul 12;3(13):e121100. doi: 10.1172/jci.insight.121100. JCI Insight. 2018. PMID: 29997290 Free PMC article.

6

Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response.

Lucas ED, Finlon JM, Burchill MA, McCarthy MK, Morrison TE, Colpitts TM, Tamburini BAJ. Lucas ED, et al. Among authors: mccarthy mk. J Immunol. 2018 Sep 15;201(6):1735-1747. doi: 10.4049/jimmunol.1800271. Epub 2018 Jul 25. J Immunol. 2018. PMID: 30045970 Free PMC article.

7

Blocking the Exit: CHIKV Neutralizing Antibodies Nip Viral Egress in the Bud.

McCarthy MK, Morrison TE. McCarthy MK, et al. Cell Host Microbe. 2018 Sep 12;24(3):328-330. doi: 10.1016/j.chom.2018.08.008. Cell Host Microbe. 2018. PMID: 30212644 Free article.

8

Chronic Chikungunya Virus Disease.

McCarthy MK, Davenport BJJ, Morrison TE. McCarthy MK, et al. Curr Top Microbiol Immunol. 2022;435:55-80. doi: 10.1007/82_2018_147. Curr Top Microbiol Immunol. 2022. PMID: 30656438

9

Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.

Hong JP, McCarthy MK, Davenport BJ, Morrison TE, Diamond MS. Hong JP, et al. Among authors: mccarthy mk. J Virol. 2019 Nov 26;93(24):e01231-19. doi: 10.1128/JVI.01231-19. Print 2019 Dec 15. J Virol. 2019. PMID: 31578287 Free PMC article.

10

Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses.

Carpentier KS, Davenport BJ, Haist KC, McCarthy MK, May NA, Robison A, Ruckert C, Ebel GD, Morrison TE. Carpentier KS, et al. Among authors: mccarthy mk. Elife. 2019 Oct 9;8:e49163. doi: 10.7554/eLife.49163. Elife. 2019. PMID: 31596239 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page